Maria L. Ascierto, Ph.D. Saint John's Cancer Institute
Por um escritor misterioso
Descrição
Saint John's Cancer Institute's Director of Translational Immunology, Maria L. Ascierto, Ph.D. Contact Dr. Ascierto via email or phone number.
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - Journal of Thoracic Oncology
Proceedings of a Workshop, The Drug Development Paradigm in Oncology: Proceedings of a Workshop
Cancers, Free Full-Text
Cancer Immunotherapy Principles and Practice by Lisa H. Butterfield PhD, eBook
Cabrini Research Annual Report 2020-21 by Cabrini Health - Issuu
Maria ASCIERTO, Post Doctoral Fellow, MS, PhD, Johns Hopkins Medicine, Maryland, JHUSOM, The Sidney Kimmel Comprehensive Cancer Center
Neil D. Gross MD Anderson Cancer Center
Antoni Ribas – UCLA Graduate Programs in Bioscience (GPB)
The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors in: Endocrine-Related Cancer Volume 27 Issue 9 (2020)
FINAL PROGRAM - Society for Immunotherapy of Cancer
Funding the Best - Saint John's Health Center Foundation
de
por adulto (o preço varia de acordo com o tamanho do grupo)
